Design Therapeutics Correlations

DSGN Stock

USD 3.81 0.06 1.55%

The current 90-days correlation between Design Therapeutics and Monte Rosa Therapeutics is 0.5 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Design Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Design Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Design Therapeutics Correlation With Market

Modest diversification

The correlation between Design Therapeutics and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Design Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Design Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Design Stock, please use our How to Invest in Design Therapeutics guide.

Moving together with Design Stock

0.7	DYAI	Dyadic International	Pair Corr
0.88	GLUE	Monte Rosa Therapeutics	Pair Corr
0.82	GNLX	Genelux Common	Pair Corr
0.91	IKNA	Ikena Oncology	Pair Corr
0.63	IMRX	Immuneering Corp	Pair Corr
0.89	LRMR	Larimar Therapeutics	Pair Corr
0.69	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.77	NAMS	NewAmsterdam Pharma	Pair Corr
0.8	ABOS	Acumen Pharmaceuticals	Pair Corr
0.82	SNDL	SNDL Inc	Pair Corr
0.87	TERN	Terns Pharmaceuticals	Pair Corr
0.86	CGEM	Cullinan Oncology LLC	Pair Corr
0.77	CMPX	Compass Therapeutics	Pair Corr
0.92	CNTA	Centessa Pharmaceuticals	Pair Corr
0.7	DAWN	Day One Biopharmaceu	Pair Corr
0.85	STRM	Streamline Health	Pair Corr

Moving against Design Stock

0.44	CAH	Cardinal Health	Pair Corr
0.37	IVA	Inventiva Sa	Pair Corr
0.59	MCK	McKesson	Pair Corr
0.36	T	ATT Inc	Pair Corr

Related Correlations Analysis

	GLUE	HOWL	IKNA	STOK	ACHL	NLTX	MGTA	GRPH	ALXO	AADI
GLUE		0.68	0.87	0.04	-0.63	0.0	0.0	0.0	0.8	0.61	GLUE
HOWL	0.68		0.74	0.29	-0.5	0.0	0.0	0.0	0.73	0.02	HOWL
IKNA	0.87	0.74		-0.02	-0.72	0.0	0.0	0.0	0.85	0.46	IKNA
STOK	0.04	0.29	-0.02		0.51	0.0	0.0	0.0	-0.18	-0.44	STOK
ACHL	-0.63	-0.5	-0.72	0.51		0.0	0.0	0.0	-0.82	-0.43	ACHL
NLTX	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	NLTX
MGTA	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	MGTA
GRPH	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	GRPH
ALXO	0.8	0.73	0.85	-0.18	-0.82	0.0	0.0	0.0		0.36	ALXO
AADI	0.61	0.02	0.46	-0.44	-0.43	0.0	0.0	0.0	0.36		AADI
	GLUE	HOWL	IKNA	STOK	ACHL	NLTX	MGTA	GRPH	ALXO	AADI

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

IKNA	+ 0.87	GLUE
ALXO	+ 0.85	IKNA
ALXO	+ 0.8	GLUE
IKNA	+ 0.74	HOWL
ALXO	+ 0.73	HOWL
HOWL	+ 0.68	GLUE

High negative correlations

ALXO	- 0.82	ACHL
ACHL	- 0.72	IKNA
ACHL	- 0.63	GLUE
ACHL	- 0.5	HOWL
AADI	- 0.44	STOK
AADI	- 0.43	ACHL

Risk-Adjusted Indicators

There is a big difference between Design Stock performing well and Design Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Design Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
GLUE	4.02	(0.57)	0.00	(0.72)	0.00	0.00	7.85	(9.02)	26.52
HOWL	4.82	0.12	0.00	(0.03)	0.00	0.00	11.69	(10.00)	30.26
IKNA	2.59	(0.27)	0.00	(0.53)	0.00	0.00	4.85	(5.83)	14.78
STOK	3.56	0.29	0.06	0.18	4.53	(3.47)	7.67	(6.88)	21.76
ACHL	1.59	0.73	0.52	0.79	0.49	(2.95)	3.47	(1.74)	22.77
NLTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MGTA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GRPH	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALXO	4.95	(1.05)	0.00	(1.51)	0.00	0.00	9.09	(11.67)	45.05
AADI	4.07	(0.06)	0.00	0.18	0.00	0.00	6.76	(8.96)	62.23

Design Therapeutics Corporate Management

Jim Kerr	Chief Development	Profile
Sean Jeffries	Chief Officer	Profile
Doane Chilcoat	Chief Officer	Profile
Elizabeth Gordon	Senior Affairs	Profile
Mustapha Parekh	General Counsel	Profile
MD FACC	Consulting Officer	Profile
Dawn Giangiulio	Controller	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC